Profiling and classification tree applied to renal epithelial tumours

Histopathology

Volumn 52, Issue 2, 2008, Pages 158-166

  Allory, Y ^a   Bazille, C ^b   Vieillefond, A ^c   Molinie V ^d   Cochand Priollet, B ^b   Cussenot, O ^e   Callard, P ^f   Sibony, M ^f  

^a HENRI MONDOR HOSPITAL   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

^c Laboratoire d'Anatomie Pathologique ^*  (France)

^d SAINT JOSEPH HOSPITAL   (France)

^e HÔPITAL TENON   (France)

^f Service d'Anatomie Pathologique   (France)

Author keywords

Chromophobe cell carcinoma; Classification tree; Clear cell carcinoma; Immunohistochemistry; Oncocytoma; Papillary carcinoma; Renal tumour

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; AQUAPORIN 1; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; EPITHELIAL MEMBRANE ANTIGEN; MUCIN 1; STEM CELL FACTOR RECEPTOR; TUMOR ANTIGEN; VIMENTIN;

ADULT; AGED; ARTICLE; AUTOMATION; CLEAR CELL CARCINOMA; COMPUTER PROGRAM; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY EPITHELIUM; KIDNEY PAPILLA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; TISSUE MICROARRAY; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; CARCINOMA, PAPILLARY; CARCINOMA, RENAL CELL; DECISION TREES; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; NEPRILYSIN; PROTEIN ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 37549068566     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02900.x     Document Type: Article

References (38)

1. Amin MB, Tamboli P, Javidan J et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 2002 26 281 291.
2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon : IARC Press, 2004.
3. Delahunt B, Eble JN. History of the development of the classification of renal cell neoplasia. Clin. Lab. Med. 2005 25 231 246.
4. Vogelzang NJ, Stadler WM. Kidney cancer. Lancet 1998 352 1691 1696.
5. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl. Immunohistochem. Mol. Morphol. 2002 10 332 338.
6. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am. J. Surg. Pathol. 2000 24 203 210.
7. Langner C, Wegscheider BJ, Ratschek M, Schips L, Zigeuner R. Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors. Virchows Arch. 2004 444 127 134.
8. Takahashi M, Yang XJ, Sugimura J et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene 2003 22 6810 6818.
9. Tan MH, Rogers CG, Cooper JT et al. Gene expression profiling of renal cell carcinoma. Clin. Cancer Res. 2004 10 6315S 6321S.
10. Yin-Goen Q, Dale J, Yang WL et al. Advances in molecular classification of renal neoplasms. Histol. Histopathol. 2006 21 325 339.
11. Zhou M, Roma A, Magi-Galluzzi C. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin. Lab. Med. 2005 25 247 257.
12. Mathers ME, Pollock AM, Marsh C, O'Donnell M. Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma. Histopathology 2002 40 563 567.
13. Abrahams NA, MacLennan GT, Khoury JD et al. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 2004 45 593 602.
14. Bazille C, Allory Y, Molinie V et al. Immunohistochemical characterisation of the main histologic subtypes of epithelial renal tumours on tissue-microarrays. Study of 310 cases. Ann. Pathol. 2004 24 395 406.
15. Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R. Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases. Mod. Pathol. 2004 17 180 188.
16. Shi T, Seligson D, Belldegrun AS, Palotie A, Horvath S. Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma. Mod. Pathol. 2005 18 547 557.
17. Tretiakova MS, Sahoo S, Takahashi M et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am. J. Surg. Pathol. 2004 28 69 76.
18. Moch H, Schraml P, Bubendorf L et al. High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. Am. J. Pathol. 1999 154 981 986.
19. Wang HY, Mills SE. KIT and RCC are useful in distinguishing chromophobe renal cell carcinoma from the granular variant of clear cell renal cell carcinoma. Am. J. Surg. Pathol. 2005 29 640 646.
20. Pan CC, Chen PC, Chiang H. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma. Am. J. Clin. Pathol. 2004 121 878 883.
21. Storkel S, Eble JN, Adlakha K et al. Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 1997 80 987 989.
22. Kovacs G, Akhtar M, Beckwith BJ et al. The Heidelberg classification of renal cell tumours. J. Pathol. 1997 183 131 133.
23. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 1998 4 844 847.
24. Skacel M, Skilton B, Pettay JD, Tubbs RR. Tissue microarrays: a powerful tool for high-throughput analysis of clinical specimens: a review of the method with validation data. Appl. Immunohistochem. Mol. Morphol. 2002 10 1 6.
25. Bubendorf L. High-throughput microarray technologies: from genomics to clinics. Eur. Urol. 2001 40 231 238.
26. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet. 2001 10 657 662.
27. Huo L, Sugimura J, Tretiakova MS et al. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas. Hum. Pathol. 2005 36 262 268.
28. Leroy X, Zerimech F, Zini L et al. MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma. Am. J. Clin. Pathol. 2002 118 47 51.
29. Lin F, Brown RE, Shen T, Yang XJ, Schuerch C. Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas. Appl. Immunohistochem. Mol. Morphol. 2004 12 153 159.
30. Petit A, Castillo M, Santos M, Mellado B, Alcover JB, Mallofre C. KIT expression in chromophobe renal cell carcinoma: comparative immunohistochemical analysis of KIT expression in different renal cell neoplasms. Am. J. Surg. Pathol. 2004 28 676 678.
31. Yamazaki K, Sakamoto M, Ohta T, Kanai Y, Ohki M, Hirohashi S. Overexpression of KIT in chromophobe renal cell carcinoma. Oncogene 2003 22 847 852.
32. Mazal PR, Exner M, Haitel A et al. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma. Hum. Pathol. 2005 36 22 28.
33. Shen SS, Krishna B, Chirala R, Amato RJ, Truong LD. Kidney-specific cadherin, a specific marker for the distal portion of the nephron and related neoplasms. Mod. Pathol. 2005 18 933 940.
34. Young AN, de Oliveira salles PG, Lim SD et al. Beta defensin-1, parvalbumin, and vimentin A panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am. J. Surg. Pathol. 2003 27 199 205.
35. Skinnider BF, Folpe AL, Hennigar RA et al. Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors. Am. J. Surg. Pathol. 2005 29 747 754.
36. Skinnider BF, Amin MB. An immunohistochemical approach to the differential diagnosis of renal tumors. Semin. Diagn. Pathol. 2005 22 51 68.
37. Martignoni G, Brunelli M, Gobbo S et al. Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal. Quant. Cytol. Histol. 2007 29 41 49.
38. Martignoni G, Pea M, Brunelli M et al. CD10 is expressed in a subset of chromophobe renal cell carcinomas. Mod. Pathol. 2004 17 1455 1463.